UPF3B Antibody

Shipped with Ice Packs
In Stock

Description

What is UPF3B Antibody?

UPF3B antibodies are reagents designed to target the UPF3B protein, a component of the NMD machinery that degrades mRNAs containing premature termination codons (PTCs). These antibodies enable researchers to investigate UPF3B's expression, localization, and interactions in cellular contexts .

  • Key Functions of UPF3B:

    • Facilitates NMD by bridging exon junction complexes (EJCs) with downstream effectors like UPF2 and UPF1 .

    • Regulates immune gene expression in olfactory sensory neurons (OSNs) and maintains olfactory receptor diversity .

    • Modulates endoplasmic reticulum (ER) stress by interacting with IRE1α, impacting ER-associated degradation .

Role of UPF3B in NMD and Disease

UPF3B is essential for RNA surveillance, with mutations linked to X-linked intellectual disability (XLID) and neurodevelopmental disorders .

Table 1: UPF3B Antibody Applications

ApplicationDetailsCitations
Western BlotDetects UPF3B (~58 kDa) in lysates (e.g., HeLa, Jurkat) .
ImmunohistochemistryLocalizes UPF3B in human tissues (testis, liver, lymphoid) .
ImmunoprecipitationIsolates UPF3B complexes with UPF2/EJC components .
Flow CytometryQuantifies UPF3B expression in fixed/permeabilized cells .

UPF3B in Olfactory and Immune Regulation

  • Olfactory Sensory Neurons (OSNs):
    UPF3B loss disrupts OSN subsets and upregulates antimicrobial genes, suggesting a role in innate immunity .

    • Mechanism: UPF3B suppresses immune-related transcripts (e.g., Notch2, Bhlhe40) via NMD .

  • ER Stress Modulation:
    UPF3B inhibits IRE1α kinase activity, linking NMD to ER stress adaptation .

Functional Redundancy with UPF3A

UPF3A compensates for UPF3B loss in NMD, maintaining mRNA surveillance in UPF3B-deficient cells .

  • Key Evidence: Co-depletion of UPF3A/UPF3B causes NMD failure, unlike single knockouts .

Validation and Technical Considerations

  • Specificity: Antibodies like ab251661 and NBP1-57232 are validated using knockout controls and orthogonal methods (e.g., siRNA) .

  • Cross-Reactivity: Some antibodies (e.g., ab269998) detect both UPF3B and UPF3A, necessitating careful experimental design .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
UPF3B antibody; RENT3B antibody; UPF3X antibody; Regulator of nonsense transcripts 3B antibody; Nonsense mRNA reducing factor 3B antibody; Up-frameshift suppressor 3 homolog B antibody; hUpf3B antibody; Up-frameshift suppressor 3 homolog on chromosome X antibody; hUpf3p-X antibody
Target Names
UPF3B
Uniprot No.

Target Background

Function
UPF3B plays a crucial role in the nonsense-mediated decay (NMD) pathway, a cellular mechanism that eliminates mRNAs containing premature stop codons. It achieves this by associating with the nuclear exon junction complex (EJC), acting as a link between the EJC core and the NMD machinery. This interaction facilitates the recruitment of UPF2 at the cytoplasmic side of the nuclear envelope, leading to the formation of an UPF1-UPF2-UPF3 surveillance complex. This complex, including UPF1 bound to release factors at the stalled ribosome, is believed to trigger the NMD process. Furthermore, UPF3B, in collaboration with UPF2, enhances both the ATPase and RNA helicase activities of UPF1. Notably, UPF3B binds to spliced mRNA upstream of exon-exon junctions. In vitro studies have shown that UPF3B can stimulate translation, a function that is independent of its association with UPF2 and components of the EJC core.
Gene References Into Functions
  1. Research has demonstrated that UPF3B (i) interacts with release factors, (ii) delays translation termination, and (iii) disassembles post-termination ribosomal complexes lacking the nascent peptide. PMID: 28899899
  2. Mutations in the UPF3B gene have been linked to Lujan-Fryns syndrome. PMID: 26358559
  3. Studies suggest that the neurodevelopmental phenotype associated with UPF3B missense mutations arises from impaired nonsense-mediated mRNA decay pathway function, leading to altered neuronal differentiation. PMID: 26012578
  4. Data indicate that SATB2 activates UPF3B expression by binding to its promoter. PMID: 23925499
  5. Evidence suggests that the p.R430X mutation in the UPF3B gene is the genetic basis for mental retardation in a specific pedigree. PMID: 22957832
  6. Research findings indicate that the UPF3B-dependent NMD pathway plays a major role in regulating the transcriptome, and its targets have significant functions in neuronal cells. PMID: 22182939
  7. Two cases with renal dysplasia and developmental delay exhibited notable clinical variability despite having the same mutation in UPF3B. PMID: 22609145
  8. Results demonstrate that, in addition to Lujan-Fryns and FG syndromes, UPF3B protein truncation mutations can also cause nonspecific XLMR. PMID: 19238151
  9. A 3.4 Angstrom resolution crystal structure of a minimal UPF3b-EJC assembly has been determined. This assembly comprises the interacting domains of five proteins (UPF3b, MAGO, Y14, eIF4AIII, and Barentsz) along with RNA and adenylyl-imidodiphosphate. PMID: 20479275
  10. A conserved domain within hUpf3b mediates an interaction with the EJC protein Y14. Y14 is essential for nonsense-mediated decay induced by tethered hUpf3b. PMID: 12718880
  11. The protein region that mediates this interaction and differentiates between hUpf3a and hUpf3b in NMD function is located in the C-terminal domain and is fully contained within a small sequence that is highly conserved in Upf3b but not Upf3a proteins. PMID: 16601204
  12. UPF3B induces nonsense-mediated decay in the cytoplasm. PMID: 17194930
  13. Three mutations result in the introduction of a premature termination codon, leading to subsequent nonsense-mediated mRNA decay of mutant UPF3B mRNA. PMID: 17704778
  14. UPF2 and UPF3b work cooperatively to stimulate both ATPase and RNA helicase activities of UPF1. PMID: 18066079
  15. Research suggests that UPF3A levels are tightly regulated by a post-transcriptional switch to maintain appropriate levels of NMD substrates in cells containing different levels of UPF3B. PMID: 19503078
  16. UPF3B binds to spliced mRNAs upstream of exon-exon junctions; it is part of mRNP complexes that are prepared for nuclear export and participate in nonsense-mediated mRNA decay. PMID: 11546873
  17. UPF3B binds to RNPS1 protein, a component of the postsplicing complex deposited 5' to exon-exon junctions. PMID: 11546874

Show More

Hide All

Database Links

HGNC: 20439

OMIM: 300298

KEGG: hsa:65109

STRING: 9606.ENSP00000276201

UniGene: Hs.103832

Involvement In Disease
Mental retardation, X-linked, syndromic, 14 (MRXS14)
Protein Families
RENT3 family
Subcellular Location
Nucleus. Cytoplasm. Note=Shuttling between the nucleus and the cytoplasm.
Tissue Specificity
Expressed in testis, uterus, prostate, heart, muscle, brain, spinal cord and placenta.

Q&A

FAQs for UPF3B Antibody in Academic Research

Advanced Research Questions

How do UPF3B and UPF3A redundantly regulate NMD, and how can this be experimentally disentangled?

  • Functional redundancy analysis:

    • Perform co-depletion experiments (UPF3A + UPF3B siRNA/KO) to assess transcriptome-wide NMD substrate accumulation via RNA-Seq .

    • Use UPF3B mutants lacking UPF2-binding domains (Δ2BD) to isolate UPF3A-specific contributions .

    • Rescue assays: Transfect UPF3B/UPF3A domain-swap constructs into dKO cells to map functional regions .

What are the implications of UPF3B-UPF1 interaction dynamics in disease models?

  • Experimental framework:

    • Generate endogenously FLAG-tagged UPF1 cell lines for IP followed by quantitative proteomics to assess UPF3B/UPF3A binding stoichiometry .

    • Correlate UPF3B-UPF1 interaction strength with disease severity in intellectual disability models using patient-derived iPSCs .

How does UPF3B-CASC3 interaction influence EJC-dependent NMD?

  • Mechanistic studies:

    • Co-IP CASC3 and UPF3B in UPF2 KO cells to test direct vs. EJC-mediated interactions .

    • Use in vitro reconstitution assays with purified EJC components to measure UPF3B binding kinetics .

Data Tables

Table 1: Key UPF3B Antibody Validation Approaches

MethodApplicationExample ResultsCitations
CRISPR KO validationSpecificity confirmationLoss of band in UPF3B KO lysates
Epitope mappingCross-reactivity assessmentNo binding to UPF3A paralog
Orthogonal siRNA/qPCRFunctional relevanceIncreased NMD substrate mRNA in knockdown

Table 2: UPF3B vs. UPF3A Functional Redundancy Evidence

ObservationExperimental ModelImplicationCitations
NMD inhibition only in dKO cellsUPF3A/UPF3B co-depletionRedundant roles in EJC bridging
UPF3A compensates in UPF3B KOHCT116 transcriptomicsModular activation of NMD pathways
UPF3B-UPF1 interaction RNA-independentFLAG-UPF1 IP assaysAlternative NMD activation mechanisms

Methodological Recommendations

  • For co-IP studies, include RNase treatment controls to distinguish RNA-dependent/independent interactions .

  • In murine models, combine antibody validation with transcriptome-wide analysis (e.g., RNA-Seq in Upf3a KO mESCs) .

  • For clinical correlations, use patient-derived cells with UPF3B mutations to assess antibody utility in diagnostic workflows .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.